Venture Catalysts Exits Pee Safe
Analysis based on 7 articles · First reported Mar 17, 2026 · Last updated Mar 18, 2026
The successful exit by Venture Catalysts from Pee Safe, with significant returns, highlights the potential for strong returns in early-stage investments in the Indian personal care market. Pee Safe's new funding round, led by OrbiMed, signals continued investor confidence in the brand's growth trajectory and expansion plans, potentially attracting more investment into similar ventures.
Venture Catalysts, an Indian early-stage investment platform, has fully exited its investment in Pee Safe, a women's hygiene and wellness brand, following a $32 million funding round led by OrbiMed. The exit, completed in January 2026, generated a 9.6x return on invested capital and a 30.53% XIRR for Venture Catalysts and its limited partners. Venture Catalysts first backed Pee Safe in 2017, supporting its expansion from toilet hygiene to a broader personal hygiene and wellness portfolio. Pee Safe's total funding now stands at $45.55 million, with existing investors like Zerodha and Natco Pharma remaining. The company plans to use the new capital to expand its offline retail presence, strengthen marketing, and deepen its reach across quick commerce and online marketplaces. This event validates patient early-stage investing and demonstrates the potential for building strong brands from India.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard